ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05033	Nicotine addiction	15/154	56/7206	3.41035107902e-13
ko04724	Glutamatergic synapse	18/154	152/7206	2.82575695732e-09
ko04721	Synaptic vesicle cycle	11/154	80/7206	8.75256895957e-07
ko04080	Neuroactive ligand-receptor interaction	25/154	423/7206	2.80585349568e-06
ko04723	Retrograde endocannabinoid signaling	14/154	175/7206	2.00958518254e-05
ko04727	GABAergic synapse	11/154	110/7206	2.05331169504e-05
ko04024	cAMP signaling pathway	17/154	279/7206	8.74342061415e-05
ko04514	Cell adhesion molecules (CAMs)	11/154	130/7206	9.6995049664e-05
ko05032	Morphine addiction	10/154	110/7206	0.00011141744463
ko05030	Cocaine addiction	8/154	73/7206	0.000150285090362
ko04728	Dopaminergic synapse	13/154	185/7206	0.000152560871866
ko05014	Amyotrophic lateral sclerosis (ALS)	8/154	74/7206	0.000165489578781
ko04742	Taste transduction	7/154	61/7206	0.000294455648711
ko04713	Circadian entrainment	10/154	136/7206	0.000628512701697
ko05031	Amphetamine addiction	8/154	91/7206	0.000687086409895
ko04720	Long-term potentiation	8/154	99/7206	0.00119878131916
ko04020	Calcium signaling pathway	13/154	265/7206	0.00428096117118
ko04010	MAPK signaling pathway	14/154	321/7206	0.00937586200788
ko04921	Oxytocin signaling pathway	10/154	209/7206	0.013858477936
ko04144	Endocytosis	14/154	342/7206	0.0189334269333
ko04930	Type II diabetes mellitus	4/154	54/7206	0.0277684706518
ko05205	Proteoglycans in cancer	1/154	271/7206	0.031322180276
ko05203	Viral carcinogenesis	1/154	277/7206	0.0315728695595
ko00604	Glycosphingolipid biosynthesis - ganglio series	2/154	14/7206	0.0348973881183
ko04911	Insulin secretion	6/154	117/7206	0.0389141476208
ko02024	Quorum sensing	2/154	15/7206	0.0397114566221
ko04920	Adipocytokine signaling pathway	5/154	89/7206	0.0413625539595
ko04261	Adrenergic signaling in cardiomyocytes	9/154	205/7206	0.042430039527